Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neuroscience Letters

• Publication date

  1999-03-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/S0304-3940(99)00101-9PMID 10218900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Antioxidant Vitamin E Modulates Amyloid β-Peptide-Induced Creatine Kinase Activity Inhibition and Increased Protein Oxidation: Implications for the Free Radical Hypothesis of Alzheimer's Disease

  1999cited by this paper
• A novel technique for visualizing the intracellular localization and distribution of transported polyamines in cultured pulmonary artery smooth muscle cells.

  1998cited by this paper
• Ornithine Decarboxylase in Human Brain: Influence of Aging, Regional Distribution, and Alzheimer's Disease

  1998cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• Free radical-induced elevation of ornithine decarboxylase activity in developing rat brain slices.

  1997cited by this paper
• beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.

  1997cited by this paper
• Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal.

  1997cited by this paper
• Amyloid β-Protein and the Genetics of Alzheimer's Disease*

  1996cited by this paper
• Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease.

  1996cited by this paper
• Polyamine transport in mammalian cells. An update.

  1996cited by this paper
• Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons.

  1995cited by this paper
• Increased immunostaining for L-ornithine decarboxylase occurs in neocortical neurons of Alzheimer's disease patients.

  1995cited by this paper
• Polyamines as targets for therapeutic intervention.

  1995cited by this paper
• Rapid and regulated degradation of ornithine decarboxylase.

  1995cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification

  1994cited by this paper
• beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

  1994cited by this paper
• β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease

  1994cited by this paper
• A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

  1994cited by this paper
• Excitatory amino acids as a final common pathway for neurologic disorders.

  1994cited by this paper
• Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination

  1993cited by this paper
• Polyamines in neurotrauma. Ubiquitous molecules in search of a function.

  1992cited by this paper
• Excitatory amino acids and Alzheimer's disease.

  1989cited by this paper
• Induction of Brain Ornithine Decarboxylase During Recovery from Metabolic, Mechanical, Thermal, or Chemical Injury

  1984cited by this paper
• Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors.

  1968cited by this paper

• Influence of high fructose intake on systemic and cognitive health across developmental stages: A review

  2025cites this paper
• The memory- and cognition-facilitating effects of spermidine in aging and aging-related disorders.

  2025cites this paper
• Polyamine biosynthesis dysregulation in Alzheimer’s disease and Down syndrome cellular models

  2025cites this paper
• Rosemarinic Acid-Induced Destabilization of Aβ Peptides: Insights from Molecular Dynamics Simulations

  2024cites this paper
• Centella asiatica improves cognitive function and alters the hippocampal metabolome of aged Tg2576 and wild-type mice

  2024cites this paper
• Metabolomics profiling reveals distinct, sex‐specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease

  2024cites this paper
• Association Between the Gut Microbiota and Alzheimer’s Disease: An Update on Signaling Pathways and Translational Therapeutics

  2024cites this paper
• New Wine in Old Bottle: Caenorhabditis Elegans in Food Science

  2023cites this paper
• Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer’s disease

  2023cites this paper
• Effects of Hydrogen Gas Inhalation on Community-Dwelling Adults of Various Ages: A Single-Arm, Open-Label, Prospective Clinical Trial

  2023cites this paper
• The Multifaceted Role of WNT Signaling in Alzheimer’s Disease Onset and Age-Related Progression

  2023cites this paper
• How Can Insulin Resistance Cause Alzheimer’s Disease?

  2023cites this paper
• The amyloid state of proteins: A boon or bane?

  2022cites this paper
• The Influence of Orthopedic Surgery on Circulating Metabolite Levels, and their Associations with the Incidence of Postoperative Delirium

  2022cites this paper
• Immunomodulation in age-related disorders and nanotechnology interventions.

  2022cites this paper
• Effects of cocoa on altered metabolite levels in purine metabolism pathways and urea cycle in Alzheimer's disease in C. elegans

  2022cites this paper
• Alzheimer’s disease as a chronic maladaptive polyamine stress response

  2021cites this paper
• Alzheimer ’ s disease as a chronic maladaptive polyamine stress response Review

  2021cites this paper
• An Interactive Review on the Role of Tocotrienols in the Neurodegenerative Disorders

  2021cites this paper
• Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection

  2021cites this paper
• Pharmacokinetic and metabolic analysis of an Alzheimer's disease therapeutic in rat serum via microfluidic CZE-MS.

  2021cites this paper
• Altered brain arginine metabolism with age in the APPswe/PSEN1dE9 mouse model of Alzheimer's disease.

  2020cites this paper
• Evidences for Agmatine alterations in Aβ1-42induced Memory Impairment in Mice.

  2020cites this paper
• Current updates on the regulation of beta-secretase movement as a potential restorative focus for management of Alzheimer's disease.

  2019cites this paper
• Potential Enzymatic Targets in Alzheimer's: A Comprehensive Review.

  2019cites this paper
• Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases

  2019cites this paper
• Cerebrospinal Fluid Spermidine, Glutamine and Putrescine Predict Postoperative Delirium Following Elective Orthopaedic Surgery

  2019cites this paper
• Multimodal Imaging of Amyloid Plaques: Fusion of the Single-probe Mass Spectrometry Image and Fluorescence Microscopy Image.

  2019cites this paper
• Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis

  2019cites this paper
• The relevance of natural compounds in the Alzheimer´s Disease

  2018cites this paper
• Influence of copper(II) ions on the noncovalent interactions between cytidine-5'-diphosphate or cytidine-5'-triphosphate and biogenic amines putrescine or spermidine.

  2018cites this paper
• Astragaloside Ⅳ Protects Against Aβ1-42-induced Oxidative Stress, Neuroinflammation and Cognitive Impairment in Rats.

  2018cites this paper
• Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

  2018cites this paper
• Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice

  2018cites this paper
• Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimer’s Disease

  2017cites this paper
• Effects of Aging and Tocotrienol-Rich Fraction Supplementation on Brain Arginine Metabolism in Rats

  2017cites this paper
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cites this paper
• 1H NMR‐based metabolomics study of liver damage induced by ginkgolic acid (15:1) in mice

  2017cites this paper
• The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review

  2016cites this paper
• Alzheimer's disease-like pathology has transient effects on the brain and blood metabolome.

  2016cites this paper
• Modulation of learning and memory by natural polyamines.

  2016cites this paper
• Altered Arginine Metabolism in Cells Transfected with Human Wild-Type Beta Amyloid Precursor Protein (βAPP).

  2016cites this paper
• Alzheimer ' s disease ( AD )-like pathology has discontinuous effects on the brain and blood metabolome

  2016cites this paper
• Effect of dietary supplementation of dates in Alzheimer's disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status

  2015cites this paper
• Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases

  2015cites this paper
• The Emerging Role of Glutathione in Alzheimer's Disease

  2014cites this paper
• Inhibition of the Polyamine System Counteracts β-Amyloid Peptide-Induced Memory Impairment in Mice: Involvement of Extrasynaptic NMDA Receptors

  2014cites this paper
• Role of agmatine in neurodegenerative diseases and epilepsy.

  2014cites this paper
• Metabolic profiling of Alzheimer's disease brains

  2013cites this paper
• α-Synuclein aggregation and modulating factors.

  2012cites this paper
• α Aggregation and Modulating Factors

  2012cites this paper
• Polyamines in aging and disease

  2011cites this paper
• Oxidative Stress in Alzheimer Disease: Synergy Between the Butterfield and Markesbery Laboratories

  2011influential citation
• Pre-aggregated Aβ(25-35) alters arginine metabolism in the rat hippocampus and prefrontal cortex.

  2011cites this paper
• VITAMIN E AND NEURODEGENERATIVE DISEASE

  2011cites this paper
• THE FUNCTIONS AND REGULATION OF ORNITHINE DECARBOXYLASE

  2010cites this paper
• Brain Neurons Express Ornithine Decarboxylase‐Activating Antizyme Inhibitor 2 with Accumulation in Alzheimer's Disease

  2010cites this paper
• Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy.

  2010cites this paper
• INVESTIGATIONS OF S-GLUTATHIONYLATION OF BRAIN PROTEINS IN THE PROGRESSION OF ALZHEIMER'S DISEASE AND OF A POTENTIAL GLUTATIONE MIMETIC AS A TREATMENT OF ALZHEIMER'S DISEASE

  2009cites this paper
• Effects of Vitamin C on Fibroblasts from Sporadic Alzheimer’s Disease Patients

  2008cites this paper
• CK2 Contributes to the Synergistic Effects of BMP7 and BDNF on Smad 1/5/8 Phosphorylation in Septal Neurons

  2008cites this paper
• Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

  2008cites this paper
• Physiological polyamines: simple primordial stress molecules

  2007cites this paper
• Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.

  2007cites this paper
• Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease

  2006cites this paper
• Gene profiling during development and after a peripheral nerve traumatism reveals genes specifically induced by injury in dorsal root ganglia.

  2006cites this paper
• Altered subcellular localization of ornithine decarboxylase in Alzheimer's disease brain.

  2006cites this paper
• The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.

  2006cites this paper
• Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease.

  2006cites this paper
• Protective effect of D609 against amyloid‐beta1–42‐induced oxidative modification of neuronal proteins: Redox proteomics study

  2006cites this paper
• Neurotoxicity and oxidative stress in D1M-substituted Alzheimer's A beta(1-42): relevance to N-terminal methionine chemistry in small model peptides.

  2005cites this paper
• Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.

  2005cites this paper
• REDOX PROTEOMICS IDENTIFICATION OF OXIDATIVELY MODIFIED PROTEINS AND THEIR PHARMACOLOGICAL MODULATION: INSIGHT INTO OXIDATIVE STRESS IN BRAIN AGING, AGE-RELATED COGNITIVE IMPAIRMENT

  2005cites this paper
• γ‐glutamylcysteine ethyl ester‐induced up‐regulation of glutathione protects neurons against Aβ(1–42)‐mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease

  2005cites this paper
• Ginkgo biloba Extract EGb 761 Extends Life Span and Attenuates H2O2 Levels in a Caenorhabditis elegans Model of Alzheimer’s Disease

  2005cites this paper
• γ‐Glutamylcysteine ethyl ester protection of proteins from Aβ(1–42)‐mediated oxidative stress in neuronal cell culture: A proteomics approach

  2005influential citation
• 5-Aminosalicylic Acid Protection against Oxidative Damage to Synaptosomal Membranes by Alkoxyl Radicals In Vitro

  2004cites this paper
• Rodent Aβ(1–42) exhibits oxidative stress properties similar to those of human Aβ(1–42): Implications for proposed mechanisms of toxicity

  2004cites this paper
• Alzheimer's amyloid β-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide

  2004cites this paper
• Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro.

  2004cites this paper
• Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

  2004cites this paper
• Antisense directed at the Aβ region of APP decreases brain oxidative markers in aged senescence accelerated mice

  2004cites this paper
• Signalling of galanin and amyloid precursor protein through adenylate cyclase

  2004cites this paper
• Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.

  2004cites this paper
• Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.

  2004cites this paper
• Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

  2004cites this paper
• Research report Antisense directed at the Ah region of APP decreases brain oxidative markers in aged senescence accelerated mice

  2004cites this paper
• Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761

  2003cites this paper
• The Glutamatergic System and Alzheimer’s Disease

  2003cites this paper
• Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

  2003cites this paper
• Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.

  2002cites this paper
• Antioxidant strategies for Alzheimer's disease

  2002cites this paper
• The Antioxidant Vitamins C and E

  2002cites this paper
• LIPID PEROXIDATION AND PROTEIN OXIDATION IN ALZHEIMER'S DISEASE BRAIN: POTENTIAL CAUSES AND CONSEQUENCES INVOLVING AMYLOID -PEPTIDE-ASSOCIATED FREE RADICAL OXIDATIVE STRESS

  2002cites this paper
• Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review

  2002cites this paper
• Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists

  2002cites this paper
• Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

  2002cites this paper
• Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer ’ s amyloid-peptide 1 – 42

  2002cites this paper
• Serial Review : Causes and Consequences of Oxidative Stress in Alzheimer ’ s Disease

  2002cites this paper
• Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

  2002cites this paper